companies us-foods-inc 
Law 360
OCTOBER 13, 2023
US Foods Inc. agreed to pay more than $721,000 total in back pay to nearly 1,000 women to resolve claims that the company discriminated against female applicants during the hiring process at five facilities, the U.S. Department of Labor said Friday.
JURIST
JUNE 26, 2022
The US Court of Appeals for the District of Columbia Circuit Friday granted Juul Labs, Inc.’s ’s emergency motion for a temporary administrative stay and thus put a hold on the Food and Drug Administration’s (FDA) ban on Juul e-cigarette sales.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JURIST
JUNE 20, 2021
The US Supreme Court on Thursday reversed a ruling that allowed several individuals to sue food corporations Nestlé USA and Cargill over child slavery claims, limiting corporate liability under the Alien Tort Statute. The case which the Supreme Court decided was Nestlé USA, Inc. Doe I, consolidated with Cargill, Inc.
JURIST
JUNE 23, 2022
The US Food and Drug Administration (FDA) Thursday issued marketing denial orders (MDOs) to all JUUL Labs Inc. products currently marketed in the US. As a result of the MDOs, JUUL must cease selling and distributing products in the US.
FDA Law Blog
MARCH 13, 2024
Men in Black from the PTO’s PTE branch might have gotten to us. Part 2 (“Part Deux”) investigated the PTO’s position and recent decisions on PTE applications for patents covering products approved—and then withdrawn years later—under the Federal Food, Drug, and Cosmetic Act’s Accelerated Approval provisions (and otherwise).
The IP Law Blog
NOVEMBER 9, 2023
Many of us have said, “Bacon makes everything better.” The dispute arose between HIP, Inc. (“HIP”) HIP”) and Hormel Foods Corporation (“Hormel”) related to work on a joint project. (“HIP”) and Hormel Foods Corporation (“Hormel”) related to work on a joint project. HIP, formerly Unitherm Food Systems, Inc.
FDA Law Blog
JANUARY 1, 2024
Perhaps FDA wanted us to remember 2023 as the year FDA succeeded in uncovering critical defects in drug and device manufacturing, and in critical trials. Warning Letters, generally made public in a batch each Tuesday, are FDA’s public sanction that is most widely used to bring pressure on manufacturers and clinical trial investigators.
Expert insights. Personalized for you.
75 
Let's personalize your content